Clinical Trial Update: Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating secretin-enhanced MRCP for evaluating known or suspected intraductal papillary mucinous neoplasms of the pancreas; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasms

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Intraductal Papillary Mucinous Neoplasms | Phase 1 | Status: TERMINATED